$ABMD {{ '2016-02-08T17:10:04+0000' | timeago}} • Announcement

Medical devices company $ABMD said it has appointed Jeannine Rivet and Christopher Van Gorder to its BoD, bringing the number of active directors to nine. Ms. Rivet is currently EVP of UnitedHealth Group and Mr. Van Gorder has been President and CEO of Scripps Health since 2000.

$SYK {{ '2018-01-09T17:21:37+0000' | timeago}} • Announcement

$SYK said that for 4Q17 its preliminary results are of net sales growth of 10% to $3.5Bil, while for FY17, its net sales grew 9.9% to $12.4Bil. Excluding the impact of foreign currency & acquisitions, net sales rose 8.1% and 7.1% in 4Q17 and FY17. For 2018, $SYK expects modest headwinds that will be manageable within its overall financial targets.

$HRC {{ '2018-01-09T17:07:14+0000' | timeago}} • Announcement

$HRC announced its preliminary 1Q18 revenue. For this period, the company expects worldwide revenue of approx $670MM, an increase of 5% YoY. Core revenue increased approx 2%, exceeding the company's previously issued guidance of flat core revenue growth.

$ABMD {{ '2018-01-08T13:26:01+0000' | timeago}} • Announcement

Medical devices company $ABMD said it expects to record revenues of $154MM in the third quarter of fiscal 2018, representing a 34% annual growth. US patient usage is estimated to increase 33% YoY during the quarter. The company raised its FY18 revenue outlook to $582MM from the earlier outlook of $565MM-$575MM.

$TFX {{ '2018-01-02T14:56:01+0000' | timeago}} • Announcement

$TFX completed its senior leadership transition. Effective Jan. 1, 2018, Liam Kelly, who was previously President & COO, assumed the position of President & CEO. Mr. Kelly succeeds Benson Smith, who retired as CEO, effective Dec. 31, 2017. Mr. Smith will continue to serve as non-executive Chairman of the Board.

$ABT {{ '2017-12-15T16:46:17+0000' | timeago}} • Announcement

$ABT increased the company's quarterly common dividend to $0.28 per share from $0.265 per share.  The cash dividend is payable Feb. 15, 2018, to shareholders of record at the close of business on Jan. 12, 2018.

$TFX {{ '2017-12-12T15:30:39+0000' | timeago}} • Announcement

$TFX's respiratory division has signed a new group purchasing agreement with HealthTrust. The Respiratory Heaters & Accessories agreement which became effective Dec. 1, 2017, covers Teleflex's full line of Active Humidification, Non Invasive Ventilation (NIV), and High Flow Nasal Cannula Therapy (HFNCT) products.

$SYK {{ '2017-12-12T14:28:46+0000' | timeago}} • Announcement

$SYK said Howard Cox Jr. has notified the company that he will not stand for re-election at Stryker's 2018 Annual Meeting, which is expected to be held on May 2, 2018. In light of Cox's immense contributions to the company, he will be named Director Emeritus.

$HLS {{ '2017-12-12T13:23:46+0000' | timeago}} • Announcement

$HLS appointed Nancy Schlichting as an independent director, effective Dec. 11, 2017. With this appointment, the Board will expand to 11 directors. Schlichting currently serves on the boards of $WBA and $HRC.

$SYK {{ '2017-12-11T21:53:53+0000' | timeago}} • Announcement

$SYK said that the simplified public tender offer for the shares and BSAAR warrants of VEXIM has closed. $SYK, which already owned over 50% of the share capital and voting rights of VEXIM, acquired an additional 4.04MM shares during the offer period, as well as 226,520 BSAAR warrants that it has exercised for new shares of VEXIM.

$ENTL {{ '2017-12-08T17:39:22+0000' | timeago}} • Announcement

Rowley Law PLLC is investigating potential claims against $ENTL and its BoD for breach of fiduciary duty concerning the proposed acquisition of the company by $SYK. Stockholders will receive $24.00 in cash for each share of $ENTL that they hold. The transaction is valued at about $662MM.

$SYK {{ '2017-12-07T16:33:56+0000' | timeago}} • Announcement

$SYK agreed to buy $ENTL for $24 per share, or an equity value of about $662MM. The transaction is expected to be dilutive to $SYK's 2018 adjusted EPS by about $0.04 and accretive thereafter. Guggenheim Securities served as financial advisor and Skadden, Arps, Slate, Meagher & Flom LLP served as outside legal counsel for $SYK.

$SYK {{ '2017-12-07T14:25:00+0000' | timeago}} • Announcement

$SYK BoD declared a quarterly dividend of $0.47 per share payable on January 31, 2018 to shareholders of record on December 29, 2017. This  represents an increase of approx. 11% compared to the prior year and the previous quarter.

$HRC {{ '2017-11-27T15:52:09+0000' | timeago}} • Announcement

IMRIS and $HRC said Hill-Rom's Trumpf Medical has completed device listing and registration with FDA for a new multi-functional operating room table specifically designed for the IMRIS Surgical Theatre. Full market launch is expected in early 2018.

$RMD {{ '2017-11-17T16:34:01+0000' | timeago}} • Announcement

$RMD elected accomplished healthcare executive Karen Drexler to its BoD. Also, Chris Roberts is retiring after serving on $RMD's Board for more than 25 years. Drexler's appointment and Roberts' retirement both took effect following the company's annual meeting of shareholders held Nov. 16.

$LHCG {{ '2017-11-16T14:14:41+0000' | timeago}} • Announcement

$LHCG-$AFAM merger will create a nationwide provider of in-home healthcare services. The combined company will have 781 locations in 36 states with more than 31,000 employees and revenue of $1.8Bil and adjusted EBITDA of approx. $145MM for the trailing 12-month period ended Sept. 30, 2017.

$LHCG {{ '2017-11-16T14:13:01+0000' | timeago}} • Announcement

$LHCG and $AFAM have agreed to combine in an all-stock merger of equals transaction. Almost Family shareholders will receive 0.9150 shares of LHC Group for each existing Almost Family share. Upon closing of the transaction, LHC Group shareholders will own 58.5% and Almost Family shareholders will own 41.5% of the combined company.

$RMD {{ '2017-11-13T19:41:35+0000' | timeago}} • Infographic

$RMD ResMed Inc Earnings AlphaGraphic: Q1 2018 Highlights

$MDCO {{ '2017-11-06T13:48:22+0000' | timeago}} • Announcement

$MDCO has initiated the phase-3 clinical program for inclisiran, a formulation for the treatment of atherosclerotic cardiovascular disease, in association with $ALNY. Patient dosing in the ORION-11 clinical trial began on November 1. The company expects data from the trials will support the submission of a New Drug Application by the end of 2019.

$SYK {{ '2017-10-27T11:50:44+0000' | timeago}} • Infographic

$SYK Stryker Corp. Earnings AlphaGraphic: Q3 2017 Highlights

$ABT {{ '2017-10-23T14:32:50+0000' | timeago}} • Announcement

$ABT secured FDA clearance in US for its Insertable Cardiac Monitor (ICM) Confirm Rx, world's first and only smartphone compatible ICM designed to help physicians remotely identify cardiac arrhythmias (CA). Once implanted with a quick, minimally-invasive outpatient procedure Confirm Rx continuously monitors heart rhythms to detect a range of CA.

Recent Transcripts

TRXC (TransEnterix, Inc.)
Thursday, November 9 2017 - 9:30pm
ALQA (Alliqua BioMedical, Inc.)
Thursday, November 9 2017 - 1:00pm
ACAD (ACADIA Pharmaceuticals Inc.)
Tuesday, November 7 2017 - 9:30pm
ALNY (Alnylam Pharmaceuticals, Inc.)
Tuesday, November 7 2017 - 9:30pm
HAE (Haemonetics Corporation)
Tuesday, November 7 2017 - 1:00pm
HRC (Hill-Rom Holdings, Inc.)
Friday, November 3 2017 - 12:00pm
ALIM (Alimera Sciences, Inc.)
Thursday, November 2 2017 - 1:00pm
TFX (Teleflex Incorporated)
Thursday, November 2 2017 - 12:00pm
LMAT (LeMaitre Vascular, Inc.)
Thursday, October 26 2017 - 9:00pm
RMD (ResMed Inc.)
Thursday, October 26 2017 - 8:30pm
SYK (Stryker Corporation)
Thursday, October 26 2017 - 8:30pm
ALKS (Alkermes plc)
Thursday, October 26 2017 - 12:30pm
Thursday, October 26 2017 - 12:00pm
ACHC (Acadia Healthcare Company, Inc.)
Wednesday, October 25 2017 - 1:00pm
ARAY (Accuray Incorporated)
Tuesday, October 24 2017 - 8:30pm
ABT (Abbott Laboratories)
Wednesday, October 18 2017 - 1:00pm
ARAY (Accuray Incorporated)
Tuesday, August 22 2017 - 8:30pm
ALQA (Alliqua BioMedical, Inc.)
Thursday, August 10 2017 - 12:00pm
ALNY (Alnylam Pharmaceuticals, Inc.)
Wednesday, August 9 2017 - 8:30pm
ACAD (ACADIA Pharmaceuticals Inc.)
Tuesday, August 8 2017 - 9:00pm

AlphaGraphics you may like